ACM
Aisling Capital Management Portfolio holdings
AUM
$360M
1-Year Est. Return
114.67%
1 Year Est. Return
+114.67%
AUM
$288M
AUM Growth
+$6.62M
(+2.3%)
Holding
15
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
BridgeBio Pharma
BBIO
$10.5B
| $210M | 72.72% |
6,068,125
|
|
||
|
VRNA
2
DELISTED
Verona Pharma
VRNA
| $39.1M | 13.54% |
615,352
-500,000
|
|
||
3
Syndax Pharmaceuticals
SNDX
$1.23B
| $12.6M | 4.36% |
1,025,000
|
|
||
|
BCAX
4
Bicara Therapeutics
BCAX
$997M
| $7.41M | 2.57% |
568,919
|
|
||
5
Monte Rosa Therapeutics
GLUE
$621M
| $6.83M | 2.37% |
1,472,331
|
|
||
6
Nuvation Bio
NUVB
$1.17B
| $4.47M | 1.55% |
2,541,009
|
|
||
|
CMPS
7
Compass Pathways
CMPS
$626M
| $3.43M | 1.19% |
1,198,418
+233,918
|
|
||
8
Biomea Fusion
BMEA
$107M
| $1.7M | 0.59% |
798,757
|
|
||
9
CalciMedica
CALC
$44.9M
| $995K | 0.35% |
521,114
|
|
||
|
ELEV
10
DELISTED
Elevation Oncology
ELEV
| $735K | 0.25% |
2,834,910
|
|
||
11
Aclaris Therapeutics
ACRS
$206M
| $665K | 0.23% |
434,455
|
|
||
12
Marker Therapeutics
MRKR
$13.2M
| $400K | 0.14% |
325,370
|
|
||
|
OKUR
13
OnKure Therapeutics
OKUR
$37.6M
| $381K | 0.13% |
88,607
|
|
||
|
VIRX
14
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| – | – |
-288,571
|
|
||
|
PSTX
15
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| – | – |
-1,043,267
|
|